These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21415265)

  • 1. Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I.
    Schönberg K; Fischer JC; Kögler G; Uhrberg M
    Blood; 2011 May; 117(19):5152-6. PubMed ID: 21415265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell development in a human stem cell niche: KIR expression occurs independently of the presence of HLA class I ligands.
    Zhao X; Weinhold S; Brands J; Hejazi M; Degistirici Ö; Kögler G; Meisel R; Uhrberg M
    Blood Adv; 2018 Oct; 2(19):2452-2461. PubMed ID: 30266820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.
    Sleiman M; Brons NH; Kaoma T; Dogu F; Villa-Forte A; Lenoble P; Hentges F; Kotsch K; Gadola SD; Vilches C; Zimmer J
    J Immunol; 2014 Mar; 192(6):2602-10. PubMed ID: 24554773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.
    Gwozdowicz S; Nestorowicz K; Graczyk-Pol E; Szlendak U; Rogatko-Koros M; Mika-Witkowska R; Pawliczak D; Zubala M; Malinowska A; Witkowska A; Nowak J
    Int J Immunogenet; 2019 Aug; 46(4):217-231. PubMed ID: 31210416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles.
    Goldenson BH; Zhu H; Wang YM; Heragu N; Bernareggi D; Ruiz-Cisneros A; Bahena A; Ask EH; Hoel HJ; Malmberg KJ; Kaufman DS
    Front Immunol; 2020; 11():561553. PubMed ID: 33178188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class I NK-epitopes and KIR diversities in patients with multiple myeloma.
    Beelen NA; Molenbroeck SJJ; Groeneveld L; Voorter CE; Bos GMJ; Wieten L
    Immunogenetics; 2024 Jun; 76(3):155-164. PubMed ID: 38478091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.
    Yawata M; Yawata N; Draghi M; Partheniou F; Little AM; Parham P
    Blood; 2008 Sep; 112(6):2369-80. PubMed ID: 18583565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human KIR repertoires: shaped by genetic diversity and evolution.
    Manser AR; Weinhold S; Uhrberg M
    Immunol Rev; 2015 Sep; 267(1):178-96. PubMed ID: 26284478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression.
    Andersson S; Fauriat C; Malmberg JA; Ljunggren HG; Malmberg KJ
    Blood; 2009 Jul; 114(1):95-104. PubMed ID: 19304956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro.
    Rose MJ; Brooks AG; Stewart LA; Nguyen TH; Schwarer AP
    J Immunol; 2009 Oct; 183(7):4502-8. PubMed ID: 19748981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.
    Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW
    Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells.
    Young NT; Rust NA; Dallman MJ; Cerundolo V; Morris PJ; Welsh KI
    Hum Immunol; 1998 Nov; 59(11):700-12. PubMed ID: 9796738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors.
    Hasenkamp J; Borgerding A; Uhrberg M; Falk C; Chapuy B; Wulf G; Jung W; Trümper L; Glass B
    Scand J Immunol; 2008 Mar; 67(3):218-29. PubMed ID: 18226015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
    Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
    Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
    Grau R; Lang KS; Wernet D; Lang P; Niethammer D; Pusch CM; Handgretinger R
    Exp Mol Pathol; 2004 Apr; 76(2):90-8. PubMed ID: 15010286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
    Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Czyż A; Gil L; Komarnicki M; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange A;
    Biol Blood Marrow Transplant; 2015 May; 21(5):829-39. PubMed ID: 25617806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.